Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ragland

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|August 8, 2024
Dysfunctional Alpha Modulation as a Mechanism of Working Memory Impairment in Serious Mental IllnessMolly A Erickson, Megan A Boudewyn, Kurt Winsler, et al.
Neuroimage. Clinical|March 11, 2019
A multicenter study of ketamine effects on functional connectivity: Large scale network relationships, hubs and symptom mechanismsLeah M Fleming, Daniel C Javitt, Cameron S Carter, et al.
JAMA Psychiatry|November 24, 2017
Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical TrialDaniel C Javitt, Cameron S Carter, John H Krystal, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|August 8, 2024
Dysfunctional Alpha Modulation as a Mechanism of Working Memory Impairment in Serious Mental IllnessMolly A Erickson, Megan A Boudewyn, Kurt Winsler, et al.
Neuroimage. Clinical|March 11, 2019
A multicenter study of ketamine effects on functional connectivity: Large scale network relationships, hubs and symptom mechanismsLeah M Fleming, Daniel C Javitt, Cameron S Carter, et al.
JAMA Psychiatry|November 24, 2017
Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical TrialDaniel C Javitt, Cameron S Carter, John H Krystal, et al.
Pageof 9